About the Company
daré bioscience (nasdaq: dare) is a clinical-stage biopharmaceutical company committed to the advancement of innovative products for women’s reproductive health. we are driven by a mission to identify, develop and bring to market a diverse portfolio of novel therapies that expand treatment options, improve outcomes and facilitate convenience for women. we are initially focused on the areas of contraception, vaginal health and fertility. our lead product candidate, ovaprene, is a non-hormonal, monthly contraceptive ring that is currently in clinical studies.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $DARE News
Daré Bioscience Announces Executive Team Transition and Board Reduction
Daré Bioscience Inc (DARE) has released an update to notify the public and investors about its officers. Lisa Walters-Hoffert, co-founder and CFO of Daré Bioscience, Inc., will retire and ...
Buy Rating Affirmed: Daré Bioscience’s Promising Market Potential and Positive FDA Engagement
Begin your TipRanks Premium journey today. Daré Bioscience (DARE) Company Description: Daré Bioscience, Inc. operates as a healthcare company, which engages in the development and ...
Buy Rating Affirmed: Daré Bioscience’s Regulatory Progress and Strategic Financing Underpin Future Growth
Begin your TipRanks Premium journey today. Daré Bioscience (DARE) Company Description: Daré Bioscience, Inc. operates as a healthcare company, which engages in the development and ...
All You Need to Know About Dare Bioscience, Inc. (DARE) Rating Upgrade to Strong Buy
Dare Bioscience, Inc. (DARE) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings estimates, which ...
DARE Daré Bioscience, Inc.
The overall quant rating is not an average of the factor grades listed. Instead, it gives greater weight to the metrics with the strongest predictive value.
Dare Bioscience Inc
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Daré Bioscience, Inc. (DARE)
Overall score is calculated based on proprietary scores based on sector averages in key company indicators: fair value, dividends, innovation, hiring, and insider sentiment. Note: if you don't see ...
Dare Bioscience Inc.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Daré Bioscience, Inc. (DARE)
Daré Bioscience, Inc. (NASDAQ:DARE) Q3 2023 Earnings Call Transcript November 9, 2023 Daré Bioscience, Inc. beats earnings expectations. Reported EPS is $-0.09, expectations were $-0.1. Operator: ...
Loading the latest forecasts...